Virtual Reality in End Stage Kidney Disease

NCT ID: NCT06356168

Last Updated: 2025-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-15

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis.

To compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression.

To compare the effects social virtual reality to individual virtual reality on quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Social Virtual Reality

Social Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Groups of 3 participants will watch a movie or program together through the glasses. They will be able to talk and interact during the session.

Group Type EXPERIMENTAL

Social Virtual Reality

Intervention Type BEHAVIORAL

Participants interact using virtual reality during dialysis.

Individual Virtual Reality

Individual Virtual Reality will be delivered using virtual reality glasses for 30-45 minutes during dialysis sessions. Those randomized to this arm will watch a movie or program alone through the glasses.

Group Type ACTIVE_COMPARATOR

Individual Virtual Reality

Intervention Type BEHAVIORAL

Participants use virtual reality alone during dialysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Social Virtual Reality

Participants interact using virtual reality during dialysis.

Intervention Type BEHAVIORAL

Individual Virtual Reality

Participants use virtual reality alone during dialysis.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month

Exclusion Criteria

* Acutely ill
* Active nausea
* Epilepsy
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lea Ann Matura, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lea Ann Matura, PhD

Role: CONTACT

2157468819

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SVR/IVR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Light Therapy in End Stage Kidney Disease
NCT06310161 NOT_YET_RECRUITING NA
Virtual Ward for Home Dialysis
NCT01912001 COMPLETED NA
Preventing Early Dialysis Starts
NCT02183987 COMPLETED NA
Frequent Hemodialysis Network: Daily Trial
NCT00264758 COMPLETED PHASE2/PHASE3
Telerehabilitation in Hemodialysis Patients.
NCT06891482 ENROLLING_BY_INVITATION NA